Harmony Biosciences ...
NasdaqGM:HRMY
$ 28,89
$-0,27 (-0,93%)
28,89 $
$-0,27 (-0,93%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
47,73%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
23,65%
Outlook 12/26
W
57,02%
Margin of safety
T
52,30%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
109,43%
Revenue growth 5Y
45,15%
Price growth 5Y
2,01%
Market Cap
$1,69 B
Long-Term Debt
$0,14 B
Short Interest
9,05%
Annual earnings
02/24/2027 (E)
Dividend
$0,00
Dividend Yield
0,00%
Industry
ISIN Number
N/A

Harmony Biosciences Holdings Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$44,00
52.3%
52.3
Last Update: 04/10/2026
Analysts: 11

Highest Price Target $62,00

Average Price Target $44,00

Lowest Price Target $25,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Harmony Biosciences Holdings
NasdaqGM:HRMY
2,01% 2,01% 0,00% 47,73% 4/6 23,65% 57,02% 50,89% DOWN
×